N-Acetyl Cysteine Protects Pulpal Stem Cells in Endodontic Revascularization (NAC)
Endodontic Disease
About this trial
This is an interventional treatment trial for Endodontic Disease
Eligibility Criteria
Inclusion Criteria:
Inclusion criteria include the following:
- Subjects will be self and parent-reported as healthy individuals with no significant medical issues.
- Radiographic assessment will determine that root(s) have not grown to completion
2) Vitality tests (cold testing with Endo ice and Electric pulp testing) will determine the tooth to be necrotic 3) Palpation and percussion tests may or may not be positive 4) Probings will be within 1-5mm 5) Patient will commit to coming to 2-3 treatment appointments lasting 1-3 hours each. Thereafter, patient will commit to come for followup recall appointments 6 and 12 months following last treatment appointment.
6) Patient must be able to tolerate sitting in a dental chair for 1-3 hours. 7) Patient will be in the age range of 6 to 18 years
Exclusion Criteria:
- Exclusion criteria include patients who cannot tolerate sitting in a dental chair due to anxiety for 1-2 hours.
Sites / Locations
- University of California, Los Angeles Dept of Graduate EndodonticsRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control
NAC Treatment
No intervention will be administered in this group as it serves as a control group.
N-Acetyl Cysteine treatment during root canal revascularization